1 Min Read
Feb 16 (Reuters) - Brainstorm Cell Therapuetics Inc
* City Of Hope to manufacture Nurown for Brainstorm’s phase 3 ALS clinical trial
Source text for Eikon:
Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.